Blog
RSS FeedPosted by Michael Wonder on 02 Aug 2023
Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (July 2023)
2 August 2023 - Multiple new documents are now available. ...
Posted by Michael Wonder on 01 Aug 2023
Global sarcoma therapy now listed on Pharmaceutical Benefits Scheme
31 July 2023 - Yondelis (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine. ...
Posted by Michael Wonder on 31 Jul 2023
Schedule of Pharmaceutical Benefits - 1 August 2023
1 August 2023 - The August 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Jul 2023
International harmonisation of ingredient names - changes to the PBS Schedule effective 1 August 2023
PBAC - The PBS Schedule has been updated in the 1 August 2023 Schedule to show sole ingredient names for ...
Posted by Michael Wonder on 26 Jul 2023
DoH publishes agenda for November 2023 PBAC meeting
26 July 2023 - The agenda for the November 2023 PBAC meeting is now available. ...
Posted by Michael Wonder on 26 Jul 2023
MSAC Secretariat publishes agenda for November 2023 MSAC meeting
26 July 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the MSAC ...
Posted by Michael Wonder on 25 Jul 2023
Peter Mac increases manufacturing centre for gene therapy bringing new hope to cancer patients
25 July 2023 - Australia’s first biomedical manufacturing facility has opened in Melbourne and will boost lifesaving therapy for cancer patients ...
Posted by Michael Wonder on 25 Jul 2023
Gilead Sciences announces its largest commitment to health equity for Australian and Canadian indigenous communities
23 July 2023 - $6 million USD in funding will help address health disparities among indigenous communities with a focus ...
Posted by Michael Wonder on 20 Jul 2023
DUSC utilisation analysis public release documents (February 2023)
20 July 2023 - The utilisation analysis public release documents from the February 2023 DUSC meeting are now available. ...
Posted by Michael Wonder on 18 Jul 2023
DoH publishes revised agenda (version 4) for July 2023 PBAC meeting
18 July 2023 - The DoH has chosen to publish another version after the event. ...
Posted by Michael Wonder on 18 Jul 2023
Outcome statement - June 2023 DUSC meeting
18 July 2023 - The outcome statement from the June 2023 DUSC meeting is now available. ...
Posted by Michael Wonder on 16 Jul 2023
Public summary documents (first time decisions not to recommend and deferrals) – March 2023 PBAC meeting
14 July 2023 - The public summary documents (first time decisions not to recommend and deferrals) from the March 2023 PBAC ...
Posted by Michael Wonder on 12 Jul 2023
Idefirix (imlifidase) receives provisional approval in Australia as desensitisation treatment in highly sensitised patients prior to kidney transplantation
11 July 2023 - Regulatory milestone marks the first time Idefirix has been approved in kidney transplantation from both living ...
Posted by Michael Wonder on 10 Jul 2023
Recommendations made out of session by the PBAC March 2023 and July 2023 meetings – changes to MS-2 Step PBS listing
11 July 2023 - In an out of session consideration, the PBAC has recommended changes to the restriction criteria and eligible ...
Posted by Michael Wonder on 10 Jul 2023
TGA decision on access to medical terminations
11 July 2023 - The Government welcomes the TGA’s decision to remove a number of restrictions on health professionals who ...